These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages]. ten Cate JW; Büller HR Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284 [TBL] [Abstract][Full Text] [Related]
3. [Clinical researchers and pharmaceutical industry]. Mees EJ Ned Tijdschr Geneeskd; 1999 Oct; 143(44):2217. PubMed ID: 10578416 [No Abstract] [Full Text] [Related]
4. Industry sponsorship and authorship of clinical trials over 20 years. Buchkowsky SS; Jewesson PJ Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982 [TBL] [Abstract][Full Text] [Related]
5. [Clinical researchers and the pharmaceutical industry]. ten Cate JW Ned Tijdschr Geneeskd; 1999 Jun; 143(26):1349-52. PubMed ID: 10416490 [TBL] [Abstract][Full Text] [Related]
7. Implications of pharmaceutical industry funding on clinical research. Lexchin JR Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137 [TBL] [Abstract][Full Text] [Related]
8. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information. Puttagunta PS; Caulfield TA; Griener G Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309 [TBL] [Abstract][Full Text] [Related]
9. Conflicts of interest in dermatology. Williams HC; Naldi L; Paul C; Vahlquist A; Schroter S; Jobling R Acta Derm Venereol; 2006; 86(6):485-97. PubMed ID: 17106594 [TBL] [Abstract][Full Text] [Related]
10. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration. James JS AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123 [TBL] [Abstract][Full Text] [Related]
11. [Dishonesty in clinical trials is expensive for the society 1]. Heslet L; Nielsen JD; Schierbeck J Ugeskr Laeger; 2003 Jun; 165(26):2671-2. PubMed ID: 12886555 [No Abstract] [Full Text] [Related]
12. [Dishonesty in clinical trials is expensive for the society 3]. Waldorff S Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557 [No Abstract] [Full Text] [Related]
13. [Dishonesty in clinical trials is expensive for the society 2]. Lund BA; Nordby G Ugeskr Laeger; 2003 Jun; 165(26):2672. PubMed ID: 12886556 [No Abstract] [Full Text] [Related]
14. Independent medical research. van der Meer JW; de Gier AM; van Swaaij WP; Katan MB Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
15. Policy of the American Society of Gene Therapy on financial conflict ofinterest in clinical research. Woo SL Mol Ther; 2000 May; 1(5 Pt 1):383-4. PubMed ID: 10979736 [No Abstract] [Full Text] [Related]
16. [The roles and responsibilities of the pharmaceutical industry]. Dejgaard A; Thomsen MK Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829 [TBL] [Abstract][Full Text] [Related]
17. How pharmaceutical industry funding affects trial outcomes: causal structures and responses. Sismondo S Soc Sci Med; 2008 May; 66(9):1909-14. PubMed ID: 18299169 [TBL] [Abstract][Full Text] [Related]
18. Industry funded clinical trials: bias and quality. Del Parigi A Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762 [TBL] [Abstract][Full Text] [Related]
19. [Medical research and the pharmaceutical industry. Uneasy bedfellows or a prenuptial agreement?]. Cohen AF Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1438-42. PubMed ID: 11503309 [TBL] [Abstract][Full Text] [Related]
20. [Pharmaceutical companies as sponsors of clinical trials--advantages and limitations]. Reis LL Rev Port Cardiol; 1992 Apr; 11(4):333-8. PubMed ID: 1632988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]